Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Very Severe COPD”

39 trials

Showing 20 of 39 results

Post-approval studies (Phase 4)Study completedNCT01966107
What this trial is testing

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.

Who this might be right for
COPDChronic Obstructive Pulmonary DiseaseModerate to Very Severe COPD
AstraZeneca 3,635
Large-scale testing (Phase 3)Study completedNCT02766608
What this trial is testing

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disorder
Pearl Therapeutics, Inc. 2,389
Large-scale testing (Phase 3)UnknownNCT05213507
What this trial is testing

Inhaled Amikacin in Preventing AECOPD

Who this might be right for
COPDCOPD Exacerbation
Shanghai Zhongshan Hospital 136
Large-scale testing (Phase 3)Study completedNCT02727660
What this trial is testing

Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)

Who this might be right for
Chronic Obstructive Pulmonary Disorder
Pearl Therapeutics, Inc. 1,876
Testing effectiveness (Phase 2)WithdrawnNCT01043601
What this trial is testing

Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

Who this might be right for
COPD
Pearl Therapeutics, Inc.
Large-scale testing (Phase 3)Study completedNCT02257385
What this trial is testing

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 967
Large-scale testing (Phase 3)Study completedNCT03162055
What this trial is testing

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease COPD
AstraZeneca 1,119
Post-approval studies (Phase 4)UnknownNCT02924870
What this trial is testing

Long-term Effect of an Health Education Program on Daily Physical Activity in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Hospital Universitario La Paz 128
Large-scale testing (Phase 3)Study completedNCT01854645
What this trial is testing

Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 2,103
Large-scale testing (Phase 3)Study completedNCT05046795
What this trial is testing

Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)

Who this might be right for
COPD
Mylan Pharma UK Ltd. 258
Large-scale testing (Phase 3)Study completedNCT02465567
What this trial is testing

Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)

Who this might be right for
COPD
Pearl Therapeutics, Inc. 8,588
Large-scale testing (Phase 3)Study completedNCT02155660
What this trial is testing

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Who this might be right for
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AstraZeneca 2,255
Large-scale testing (Phase 3)Study completedNCT01782326
What this trial is testing

QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 3,362
Early research (Phase 1)Study completedNCT03906045
What this trial is testing

A Scintigraphy Study of PT010 in COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 18
Not applicableStudy completedNCT02128529
What this trial is testing

Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseChronic Bronchitis
AstraZeneca 976
Large-scale testing (Phase 3)Study completedNCT02454959
What this trial is testing

Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD

Who this might be right for
COPD
Pearl Therapeutics, Inc. 80
Large-scale testing (Phase 3)Study completedNCT02536508
What this trial is testing

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Pearl Therapeutics, Inc. 627
Large-scale testing (Phase 3)Study completedNCT01970878
What this trial is testing

Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Pearl Therapeutics, Inc. 892
Large-scale testing (Phase 3)Looking for participantsNCT06878261
What this trial is testing

Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 990
Large-scale testing (Phase 3)Study completedNCT02347072
What this trial is testing

24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo

Who this might be right for
COPD
Pearl Therapeutics, Inc. 80
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation